Cargando…
PD-L1 in Combination with CD8(+)TIL and HIF-1α are Promising Prognosis Predictors of Head and Neck Squamous Cell Carcinoma
OBJECTIVE: The aim of this study was to evaluate the prognosis effect of PD-L1 in combination with CD8(+) tumor-infiltrating lymphocyte (TIL) or HIF-1α in head and neck squamous cell carcinoma (HNSCC). METHODS: A total of 63 patients who underwent surgical resection were included in this study. The...
Autores principales: | Zhou, Zihan, Mu, Dianbin, Zhang, Dexian, Zhang, Xianbin, Ding, Xingchen, Yang, Jia, Bai, Xinbin, Hu, Man |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767713/ https://www.ncbi.nlm.nih.gov/pubmed/33380831 http://dx.doi.org/10.2147/CMAR.S285691 |
Ejemplares similares
-
Expressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisions
por: Teng, Feifei, et al.
Publicado: (2016) -
An evaluation of autologous tumor-reactive TIL generation from head and neck squamous cell cancers
por: Mougdil, Tarsem, et al.
Publicado: (2015) -
PD-L1 and HIF-2α Upregulation in Head and Neck Paragangliomas after Embolization
por: Fischer, Alessa, et al.
Publicado: (2023) -
Uncovering PD-L1 and CD8(+) TILS Expression and Clinical Implication in Cervical Squamous Cell Carcinoma
por: Chen, Jingjing, et al.
Publicado: (2020) -
PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2022)